cervical adenosquamous carcinoma (Cancer)
Information
- Disease name
- cervical adenosquamous carcinoma
- Disease ID
- DOID:5636
- Description
- "A cervical carcinoma that derives_from squamous cells and gland-like cells." [url:http\://en.wikipedia.org/wiki/Adenosquamous_carcinoma]
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT02257528 | Active, not recruiting | Phase 2 | Nivolumab in Treating Patients With Persistent, Recurrent, or Metastatic Cervical Cancer | May 18, 2015 | March 4, 2025 |
| NCT04622670 | Active, not recruiting | N/A | Yoga Therapy During Chemotherapy and Radiation Treatment for the Improvement of Physical and Emotional Well-Being in Patients With Stage IB2-IIIB Cervical Cancer | March 10, 2020 | January 31, 2025 |
| NCT01649089 | Active, not recruiting | N/A | Studying the Physical Function and Quality of Life Before and After Surgery in Patients With Stage I Cervical Cancer | June 5, 2013 | December 1, 2025 |
| NCT02466971 | Active, not recruiting | Phase 3 | Testing the Addition of a New Anti-Cancer Drug, Triapine, to the Usual Chemotherapy Treatment (Cisplatin) During Radiation Therapy for Advanced-stage Cervical and Vaginal Cancers | May 10, 2016 | September 21, 2024 |
| NCT03738228 | Active, not recruiting | Phase 1 | Atezolizumab Before and/or With Chemoradiotherapy in Immune System Activation in Patients With Node Positive Stage IB2, II, IIIB, or IVA Cervical Cancer | January 7, 2019 | September 21, 2024 |
| NCT02020707 | Active, not recruiting | Phase 1 | Nab-Paclitaxel and Bevacizumab in Treating Patients With Unresectable Stage IV Melanoma or Gynecological Cancers | February 24, 2014 | June 30, 2025 |
| NCT00217633 | Completed | Phase 2 | Pelvic Exenteration in Treating Patients With Recurrent Cervical Cancer | January 2006 | |
| NCT00309959 | Completed | Phase 2 | ABI-007 in Treating Patients With Persistent or Recurrent Cervical Cancer | November 2006 | |
| NCT00369122 | Completed | Phase 2 | Bevacizumab, Radiation Therapy, and Cisplatin in Treating Patients With Previously Untreated Locally Advanced Cervical Cancer | August 11, 2006 | December 15, 2016 |
| NCT00460356 | Completed | Glycoprotein and Glycan in Tissue and Blood Samples of Patients With Stage IB-IVA Cervical Cancer Undergoing Surgery to Remove Pelvic and Abdominal Lymph Nodes | April 2, 2007 | July 16, 2016 | |
| NCT00803062 | Completed | Phase 3 | Paclitaxel and Cisplatin or Topotecan With or Without Bevacizumab in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical Cancer | April 2009 | February 2013 |
| NCT00897442 | Completed | Collecting Tumor Samples From Patients With Gynecological Tumors | June 1992 | ||
| NCT01026792 | Completed | Phase 2 | Temsirolimus in Treating Patients With Cervical Cancer That Is Recurrent, Locally Advanced, Metastatic, or Cannot Be Removed By Surgery | December 2009 | November 2012 |
| NCT01266447 | Completed | Phase 2 | Veliparib, Topotecan Hydrochloride, and Filgrastim or Pegfilgrastim in Treating Patients With Persistent or Recurrent Cervical Cancer | February 2011 | January 2016 |
| NCT00017004 | Completed | Phase 3 | Radiation Therapy and Cisplatin With or Without Epoetin Alfa in Treating Patients With Cervical Cancer and Anemia | August 2001 | |
| NCT01267253 | Completed | Phase 2 | Brivanib Alaninate in Treating Patients With Persistent or Recurrent Cervical Cancer | April 4, 2011 | February 28, 2014 |
| NCT01281852 | Completed | Phase 1 | Paclitaxel, Cisplatin, and Veliparib in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer | March 14, 2011 | February 11, 2017 |
| NCT01414608 | Completed | Phase 3 | Cisplatin and Radiation Therapy With or Without Carboplatin and Paclitaxel in Patients With Locally Advanced Cervical Cancer | January 9, 2012 | July 9, 2021 |
| NCT01711515 | Completed | Phase 1 | Chemoradiation Therapy and Ipilimumab in Treating Patients With Stages IB2-IIB or IIIB-IVA Cervical Cancer | October 1, 2012 | July 17, 2020 |
| NCT01759355 | Completed | Hybrid PET/MR in the Therapy of Cervical Cancer | October 2012 | May 28, 2020 | |
| NCT01266460 | Completed | Phase 2 | Vaccine Therapy in Treating Patients With Persistent or Recurrent Cervical Cancer | May 23, 2011 | October 2, 2018 |
| NCT00039442 | Completed | Phase 2 | Capecitabine in Treating Patients With Persistent or Recurrent Cervical Cancer | April 29, 2002 | |
| NCT00057863 | Completed | Phase 2 | Oxaliplatin and Paclitaxel in Treating Patients With Locally Recurrent or Metastatic Cervical Cancer | January 2003 | March 2010 |
| NCT00064077 | Completed | Phase 3 | Comparison of Four Combination Chemotherapy Regimens Using Cisplatin in Treating Patients With Stage IVB, Recurrent, or Persistent Cancer of the Cervix | May 2003 | January 30, 2018 |
| NCT00068549 | Completed | Phase 1 | Radiation Therapy Plus Cisplatin and Gemcitabine in Treating Patients With Cervical Cancer | October 2003 | |
| NCT00104910 | Completed | Phase 1 | Cetuximab, Cisplatin, and Radiation Therapy in Treating Patients With Stage IB, Stage II, Stage III, or Stage IVA Cervical Cancer | January 2005 | |
| NCT02921269 | Completed | Phase 2 | Atezolizumab and Bevacizumab in Treating Patients With Recurrent, Persistent, or Metastatic Cervical Cancer | March 10, 2017 | January 13, 2021 |
| NCT04574635 | Recruiting | Human Papilloma Virus (HPV) Circulating Tumor DNA (ctDNA) in Cervical Cancer | November 17, 2020 | November 30, 2025 | |
| NCT00070317 | Terminated | N/A | Lymph Node Mapping and Sentinel Lymph Node Identification in Patients With Stage IB1 Cervical Cancer | June 2004 | January 2013 |
| NCT00924066 | Terminated | Phase 2 | Ixabepilone to Treat Cervical Cancer | November 2008 | December 2013 |
| NCT01992861 | Terminated | MRI and PET Imaging in Predicting Treatment Response in Patients With Stage IB-IVA Cervical Cancer | February 14, 2014 | January 2022 | |
| NCT01101451 | Unknown status | Phase 3 | Radiation Therapy With or Without Chemotherapy in Patients With Stage I-IIA Cervical Cancer Who Previously Underwent Surgery | April 12, 2010 | |
| NCT01295502 | Unknown status | Phase 1 | Cisplatin and Radiation Therapy Followed by Paclitaxel and Carboplatin in Treating Patients With Stage IB-IVA Cervical Cancer | April 4, 2011 | |
| NCT03834571 | Withdrawn | Phase 2 | Testing the Addition of Paclitaxel and Carboplatin Given After Standard Chemotherapy and Radiation for Cervical Cancer in HIV-positive Women | May 31, 2022 | January 2025 |
- Disase is a (Disease Ontology)
- DOID:4362
- Cross Reference ID (Disease Ontology)
- NCI:C4519
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:254888007
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0346202
- Exact Synonym (Disease Ontology)
- Adenosquamous carcinoma of cervix
- Exact Synonym (Disease Ontology)
- Adenosquamous cell carcinoma of the Cervix Uteri